About Urinalysis
Urinalysis is the physical, chemical, and microscopic examination of urine to detect and measure various compounds that pass through the urine. Minute crystals and other abnormalities such as protein content in urine can also be detected by the test. In addition, it helps detect various diseases such as urinary tract infections (UTIs), kidney disorders, liver problems, diabetes, or other metabolic conditions.
Technavio’s analysts forecast the global urinalysis market to grow at a CAGR of 4.27% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global urinalysis market for 2017-2021. To calculate the market size, the report considers revenue generated from sales/volume/value of urinalysis products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Urinalysis Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• ARKRAY
• Beckman Coulter
• Bio-Rad
• F. Hoffmann-La Roche
• Siemens Healthineers
Other prominent vendors
• 77 Elektronica
• Analyticon Biotechnologies
• BD
• BBI Solutions
• BioPacific Diagnostic
• Dirui
• EKF Diagnostics
• Globe Scientific
• Hardy Diagnostics
• Human Diagnostics
• KOVA
• Medline
• Menarini
• Smart Medical
• Stellar Scientific
• Trinity Biotech
• TradeMed
• ulti med Products
• URIT Medical
Market driver
• Rising prevalence of UTI in hospitals
• For a full, detailed list, view our report
Market challenge
• Decrease in traditional manual sediment analysis of urine
• For a full, detailed list, view our report
Market trend
• Integration of connectivity solutions for home care settings
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Market overview
• Urinalysis consumables market
• Urinalysis instruments market
PART 07: Market segmentation by end-user
• Market overview
• Hospitals and clinics
• Diagnostic laboratories
• Home care settings
PART 08: Geographical segmentation
• Market overview
• Urinalysis market in Americas
• Urinalysis market in EMEA
• Urinalysis market in APAC
PART 09: Drivers and challenges
• Market drivers
• Market challenges
PART 10: Market trends
PART 11: Vendor landscape
• Competitive landscape
PART 12: Key vendor analysis
• Alere
• ARKRAY
• Beckman Coulter
• Bio-Rad
• F. Hoffmann-La Roche
• Siemens Healthineers
• Key companies to watch
• Other prominent vendors
PART 13: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Market outline of global urinalysis market 2016
Exhibit 02: Global urinalysis market by application 2016
Exhibit 03: Market overview of global urinalysis market 2016
Exhibit 04: Global urinalysis market 2016-2021 ($ millions)
Exhibit 05: Cost of urine tests 2016
Exhibit 06: Five forces analysis
Exhibit 07: Market segmentation of urinalysis products
Exhibit 08: Overview of urinalysis consumables market
Exhibit 09: Global urinalysis consumables market 2016-2021 ($ millions)
Exhibit 10: Market overview of urinalysis instruments market
Exhibit 11: Global urinalysis instruments market 2016-2021 ($ millions)
Exhibit 12: Global urinalysis market by end-users 2016
Exhibit 13: Market overview of hospitals and clinics 2016
Exhibit 14: Market overview of diagnostic laboratories in global urinalysis market 2016
Exhibit 15: Market overview of home care settings in global urinalysis market 2016
Exhibit 16: Buying criteria analysis: Global urinalysis market 2016
Exhibit 17: Global urinalysis market by geography 2016 and 2021 ($ millions)
Exhibit 18: Americas: Overview of urinalysis market
Exhibit 19: Urinalysis market in Americas 2016-2021 ($ millions)
Exhibit 20: EMEA: Overview of urinalysis market
Exhibit 21: Urinalysis market in EMEA 2016-2021 ($ millions)
Exhibit 22: APAC: Overview of urinalysis market
Exhibit 23: Urinalysis market in APAC 2016-2021 ($ millions)
Exhibit 24: CPT codes for urinalysis its descriptions
Exhibit 25: Competitive structure analysis of global urinalysis market 2016
Exhibit 26: Competitive landscape of global urinalysis market 2016
Exhibit 27: Strategies for large and small companies in global urinalysis market 2016
Exhibit 28: Alere: Key highlights
Exhibit 29: Alere: Strength assessment
Exhibit 30: Alere: Strategy assessment
Exhibit 31: Alere: Opportunity assessment
Exhibit 32: ARKRAY: Key highlights
Exhibit 33: ARKRAY: Strength assessment
Exhibit 34: ARKRAY: Strategy assessment
Exhibit 35: ARKRAY: Opportunity assessment
Exhibit 36: Beckman Coulter: Key highlights
Exhibit 37: Beckman Coulter: Strength assessment
Exhibit 38: Beckman Coulter: Strategy assessment
Exhibit 39: Beckman Coulter: Opportunity assessment
Exhibit 40: Bio-Rad: Key highlights
Exhibit 41: Bio-Rad: Strength assessment
Exhibit 42: Bio-Rad: Strategy assessment
Exhibit 43: Bio-Rad: Opportunity assessment
Exhibit 44: F. Hoffmann-La Roche: Key highlights
Exhibit 45: F. Hoffmann-La Roche: Strength assessment
Exhibit 46: F. Hoffmann-La Roche: Strategy assessment
Exhibit 47: F. Hoffmann-La Roche opportunity assessment
Exhibit 48: Siemens Healthineers: Key highlights
Exhibit 49: Siemens Healthineers: Strength assessment
Exhibit 50: Siemens Healthineers: Strategy assessment
Exhibit 51: Siemens Healthineers: Opportunity assessment
